Increased Alix (apoptosis-linked gene-2 interacting protein X) immunoreactivity in the degenerating striatum of rats chronically treated by 3-nitropropionic acid.

Abstract : Chronic intoxication by 3-nitropropionic acid in the Lewis rat reproduces many features reminiscent of Huntington's disease including behavioural alterations and cortico-striatal degeneration. In particular, in this model, striatal degeneration is accompanied by calpain activation as found in the human disease. The present study was undertaken to determine whether the expression of Alix (apoptosis linked gene-2 interacting protein), a widespread protein involved in neuronal death, would be modified in the striatum and cortex of 3NP-treated rats. The results clearly show that Alix immunoreactivity is increased in the neuronal cell bodies of the lateral striatum, where degeneration is massive. The medial striatum and the cortex that lack neurodegeneration remain only weakly labelled. This is further evidence suggesting an involvement of Alix in the events driving neuronal death.
Type de document :
Article dans une revue
Neuroscience Letters, Elsevier, 2004, 368 (3), pp.309-13. 〈10.1016/j.neulet.2004.07.046〉
Liste complète des métadonnées

Littérature citée [29 références]  Voir  Masquer  Télécharger

http://www.hal.inserm.fr/inserm-00381837
Contributeur : Sandrine Fraboulet <>
Soumis le : mardi 19 juillet 2011 - 11:30:04
Dernière modification le : lundi 19 janvier 2015 - 11:49:49
Document(s) archivé(s) le : vendredi 2 décembre 2016 - 16:53:31

Fichier

 Accès restreint
Fichier visible le : jamais

Connectez-vous pour demander l'accès au fichier

Identifiants

Collections

UGA

Citation

David Blum, Fiona Hemming, Marie-Christine Galas, Sakina Torch, Laetitia Cuvelier, et al.. Increased Alix (apoptosis-linked gene-2 interacting protein X) immunoreactivity in the degenerating striatum of rats chronically treated by 3-nitropropionic acid.. Neuroscience Letters, Elsevier, 2004, 368 (3), pp.309-13. 〈10.1016/j.neulet.2004.07.046〉. 〈inserm-00381837〉

Partager

Métriques

Consultations de la notice

236